THE CORPORATE LIBRARY

Related Party Transactions and Outside Related Director Information

Varian Medical Systems, Inc. (VAR)

12/29/2005 Proxy Information

Dr. Hellman is employed as the A. N. Pritzker Distinguished Service Professor in the Department of Radiation and Cellular Oncology at the University of Chicago. The Company has and does sell its products and services to the University of Chicago in the ordinary course of business. In fiscal years 2005, 2004 and 2003, The University of Chicago paid the Company approximately $150,000, $105,000, and $637,000, respectively, for products and services. The University of Chicago’s revenues were approximately $2.1 billion, $1.9 billion and $1.8 billion, respectively, in 2005, 2004 and 2003. Based on its understanding of these transactions and Dr. Hellman’s roles at the University of Chicago, the Board has determined that Dr. Hellman does not have a direct or indirect material interest in any of these transactions or otherwise have any relationship that is inconsistent with a determination that he is independent and is therefore “independent” for purposes of the Exchange Act and New York Stock Exchange listing requirements and under the Company’s Corporate Governance Guidelines.

Dr. Lichter is employed as the Dean of the University of Michigan Medical School. The Company has and does sell its products and services and does pay patent license fees to the University of Michigan in the ordinary course of business. In fiscal years 2005, 2004 and 2003, The University of Michigan paid the Company approximately $310,000, $130,000, and $1,520,000, respectively, for products and services and the Company paid The University of Michigan approximately $1,675,000, $1,255,000 and $888,000 in patent license fees. The University of Michigan’s revenues were approximately $3.9 billion in 2004 and $3.9 billion in 2003. No revenues have been published for 2005. The Board has determined that Dr. Lichter does not have a direct or indirect material interest in any of these transactions and is “independent” for purposes of the Exchange Act and New York Stock Exchange listing requirements and under the Company’s Corporate Governance Guidelines.

Additionally, Ms. Bostrom, Dr. Hellman and Dr. Lichter each serve as an outside director or on the scientific advisory committee of organizations that are customers of the Company. The Board has determined that such relationships are immaterial and are not inconsistent with a determination that the director is “independent” for purposes of the Exchange Act and New York Stock Exchange listing requirements and under the Company’s Corporate Governance Guidelines.

11/23/2005 8K Information

Mr. Levy has been Chairman of Varian Medical Systems, Inc. since February 2003 and non-executive Chairman since February 2006. He was Chief Executive Officer from April 1999 until mid-February 2006. He was President from April 1999 to mid-August 2005 and Executive Vice President from 1990 to April 1999.

12/28/2004 Proxy Information

Dr. Hellman is employed as the A. N. Pritzker Distinguished Service Professor in the Department of Radiation and Cellular Oncology at the University of Chicago. The Company has and does sell its products and services to the University of Chicago in the ordinary course of business. In fiscal years 2004, 2003 and 2002, the Company was paid approximately $105,000, $637,000 and $0, respectively, for products and services from The University of Chicago. The University of Chicago’s revenues were approximately $1.8 billion in 2003 and $1.7 billion in 2002. No revenues have been published for 2004. The Board has determined that Dr. Hellman does not have a direct or indirect material interest in any of these transactions and is an “independent director” as defined in the Exchange Act and New York Stock Exchange listing requirements and under the Company’s Corporate Governance Guidelines.

Dr. Lichter is employed as the Dean of the University of Michigan Medical School. The Company has and does sell its products and services to the University of Michigan in the ordinary course of business. In fiscal years 2004, 2003 and 2002, the Company was paid approximately $128,000, $1,520,000 and $721,000, respectively, for products and services from The University of Michigan. The University of Michigan’s revenues were approximately $3.9 billion in 2004, $3.9 billion in 2003 and $3.6 billion in 2002. The Board has determined that Dr. Lichter does not have a direct or indirect material interest in any of these transactions and is an “independent director” as defined in the Exchange Act and New York Stock Exchange listing requirements and under the Company’s Corporate Governance Guidelines.

12/30/2003 Proxy Information

No related party transactions or special relationships reported for this company. Director relationships marked "Outside Related" at this firm will most often be former executives of the company. Additional information regarding these relationships will be added during our regular updates.